J Periodontal Implant Sci.  2014 Apr;44(2):71-78. 10.5051/jpis.2014.44.2.71.

Herbal anti-inflammatory immunomodulators as host modulators in chronic periodontitis patients: a randomised, double-blind, placebo-controlled, clinical trial

• Deore GD
• Gurav AN
• Patil R
• Shete AR
• Naiktari R
• Inamdar SP

• KMID: 1914507
• DOI: http://doi.org/10.5051/jpis.2014.44.2.71

Abstract

PURPOSE
Host modulatory therapy has been proposed as a treatment for periodontal diseases. A class of herbal medicines, known to be immunomodulators, alters the activity of immune function through the regulation of informational molecules such as cytokines. In the current study, we tested the hypothesis that herbal immunomodulator drugs act as an adjuvant to scaling and root planing (SRP) in alleviating periodontal inflammation by improving clinical and biochemical parameters.
METHODS
Sixty healthy subjects (30 in each group) with moderate and severe chronic periodontitis were enrolled in a double-blind, placebo-controlled, double-masked randomised controlled trial. The control group was treated with SRP and a placebo, whereas the test group was treated with SRP followed by dietary supplementation of Septilin for 3 weeks. Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluated for all patients at the baseline, 3 weeks, and 6 weeks.
RESULTS
Improved gingival index scores found in the test group as compared to the control group were found to be statistically significant only after 3 weeks (P<0.001). In contrast, the decrease in the sulcus bleeding index and pocket depth scores was statistically highly significant in the test group as compared to the control group after 3 weeks and 6 weeks (P<0.001). However, reduced clinical attachment level and CRP scores, as reflected in the test group as compared to the control group, were not found to be statistically significant after both 3 weeks (P>0.05) and 6 weeks (P>0.05).
CONCLUSIONS
The results of this clinical-biochemical study suggest that dietary supplementation with herbal immunomodulatory agents may be a promising adjunct to SRP and may aid in improving periodontal treatment outcomes.

Keyword

C-reactive protein; Herbal medicine; Periodontitis; Randomized controlled trial

MeSH Terms

C-Reactive Protein
Chronic Periodontitis*
Cytokines
Dietary Supplements
Hemorrhage
Herbal Medicine
Humans
Immunologic Factors*
Inflammation
Periodontal Diseases
Periodontal Index
Periodontitis
Root Planing
C-Reactive Protein
Cytokines
Immunologic Factors

Figure

• 

  Figure 1 Participant flow.

Reference

1. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000. 2000; 24:239–252.

2. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents: a systematic review. Ann Periodontol. 2003; 8:12–37.

3. Bhatavadekar NB, Williams RC. New directions in host modulation for the management of periodontal disease. J Clin Periodontol. 2009; 36:124–126.

4. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol. 2005; 32:Suppl 6. 108–129.

5. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000; 78:252–257.

6. Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006; 11:128–150.

7. Kim MS, Yi JM, Kim SH, Hong SH, Kim HM. Madimadi, Korean folk medicine, blocks TNF-alpha, IL-1beta, and IL-8 production by activated human immune cells. Cytokine. 2004; 25:179–186.

8. Plaeger SF. Clinical immunology and traditional herbal medicines. Clin Diagn Lab Immunol. 2003; 10:337–338.

9. Udupa AL, Rao SG, Kulkarni DR. Wound healing profile of Septilin. Indian J Physiol Pharmacol. 1989; 33:39–42.

10. Praveenkumar V, Kuttan R, Kuttan G. Immunopotentiating activity of septilin. Indian J Exp Biol. 1997; 35:1319–1323.

11. Daswani BR, Yegnanarayan R. Immunomodulatory activity of septilin, a polyherbal preparation. Phytother Res. 2002; 16:162–165.

12. Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf. 2008; 17:523–532.

13. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008; 35:277–290.

14. Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, Passos JS, Teixeira de Freitas CO, Aragao Farias NS, et al. Chronic periodontitis and C-reactive protein levels. J Periodontol. 2011; 82:969–978.

15. Varma RS, Ashok G, Vidyashankar S, Patki P, Nandakumar KS. Anti-inflammatory properties of Septilin in lipopolysaccharide activated monocytes and macrophage. Immunopharmacol Immunotoxicol. 2011; 33:55–63.

16. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007; 78:7 Suppl. 1387–1399.

17. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012; 10:28–55.

18. Moore CP. Immunomodulating agents. Vet Clin North Am Small Anim Pract. 2004; 34:725–737.

19. Gani DK, Lakshmi D, Krishnan R, Emmadi P. Evaluation of C-reactive protein and interleukin-6 in the peripheral blood of patients with chronic periodontitis. J Indian Soc Periodontol. 2009; 13:69–74.

20. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol. 2003; 30:334–340.

21. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res. 2000; 79:49–57.

22. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens. 2003; 21:1787–1803.

23. Soeken KL, Miller SA, Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2003; 42:652–659.

24. Sharma SB, Ray S. Effect of herbal preparation on immune response of immunosuppressed mice. Indian J Physiol Pharmacol. 1997; 41:293–296.

25. Grewal DS, Sharma BK, Shah DD, Sheode JH. Septilin and geriforte in allergic and vasomotor rhinitis. Auris Nasus Larynx. 1985; 12:95–101.

26. Khanna N, Sharma SB. Anti-inflammatory and analgesic effect of herbal preparation: septilin. Indian J Med Sci. 2001; 55:195–202.

27. Shetty S, Bose A, Sridharan S, Satyanarayana A, Rahul A. A clinico-biochemical evaluation of the role of a herbal (Ayurvedic) immunomodulator in chronic periodontal disease: a pilot study. Oral Health Dent Manag. 2013; 12:95–104.

28. Ju HK, Baek SH, An RB, Bae K, Son KH, Kim HP, et al. Inhibitory effects of nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis factor-alpha production in lipopolysaccharide activated macrophages. Biol Pharm Bull. 2003; 26:1375–1378.

29. Van Dyke TE, Lester MA, Shapira L. The role of the host response in periodontal disease progression: implications for future treatment strategies. J Periodontol. 1993; 64:8 Suppl. 792–806.

30. Howell TH, Fiorellini J, Weber HP, Williams RC. Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in beagle dogs. J Periodontal Res. 1991; 26(3 Pt 1):180–183.

31. Abernethy TJ, Avery OT. The occurrence during acute infections of a protein not normally present in the blood: I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with c polysaccharide of pneumococcus. J Exp Med. 1941; 73:173–182.

32. Hedlund P. Clinical and experimental studies on C-reactive protein (acute phase protein). Acta Med Scand Suppl. 1961; 361:1–71.

33. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930; 52:561–571.

34. Perlman E, Bullowa JG, Goodkind R. An immunological and electrophoretic comparison of the antibody to c polysaccharide and the C-reactive protein of acute phase serum. J Exp Med. 1943; 77:97–110.

35. Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V, et al. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis. 2002; 2:30.

36. Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol. 2003; 74:1231–1236.

37. D'Aiuto F, Parkar M, Andreou G, Brett PM, Ready D, Tonetti MS. Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol. 2004; 31:402–411.

38. D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res. 2004; 39:236–241.

39. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005; 84:269–273.

40. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C, et al. Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J Clin Periodontol. 2005; 32:188–192.